The Lubrizol Corporation has announced that it has signed an agreement to purchase Lipotec SA, a leader in the development, manufacturing and sales of personal care ingredients based on three core technologies: peptide-based active cosmetic ingredients, delivery systems and biotechnology products.
The purchase includes Lipotec’s cosmetic active ingredients business and its subsidiaries, Diverdrugs and Lipofoods. Founded in 1987 and headquartered in Barcelona, Spain, Lipotec, part of Lipotec Group, is a leading global supplier of cosmetic peptides, a key performance ingredient in skin care products. In addition to peptides and delivery systems, Lipotec has a growing business in biotechnology ingredients for personal care. Recognised Lipotec brands include Argireline, Snap 8, Antarcticine and Eyeseryl. Diverdrugs is the research and development division of Lipotec, specialising in new active compounds in the field of cosmetics and dermatology. Lipofoods develops and manufactures functional health ingredients for the food and beverage industry. The current owners of Lipotec Group will continue their activities in the pharmaceutical and cosmetic finished goods segments through BCN Peptides, GP Pharm and Prima-Derm which are not part of this transaction. “This acquisition follows our 2011 acquisitions of Nalco’s conditioning polymer business and Active Organics botanical extracts and natural performance ingredients,” commented Rick Tolin, Lubrizol vice president and general manager, personal and home care. “Adding Lipotec further illustrates our commitment to providing a broad product portfolio, new technology and applications expertise that enhance Lubrizol’s ability to make customers successful through expanded access to innovative ingredients.” Lipotec has a strong history of innovation and focuses on high-performance applications in skin care that include anti-ageing, anti-wrinkle, sensitive skin protection and moisturising. This innovation is exemplified by Argireline, one of the most successful active ingredients ever launched in the cosmetic market. The company serves an international portfolio of customers in more than 45 countries, from multinational corporations to regional leaders. Once the transaction closes, Lipotec will become a part of Lubrizol Advanced Materials, with Lipotec, Diverdrugs and Lipofoods retaining their respective names.
